{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:12:31Z","timestamp":1788336751773,"version":"build-2803163510"},"reference-count":31,"publisher":"Maximum Academic Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PEDI"],"published-print":{"date-parts":[[2026]]},"DOI":"10.48130\/pedi-0026-0009","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:48:16Z","timestamp":1788310096000},"page":"0-0","source":"Crossref","is-referenced-by-count":0,"title":["Bihormonal fully closed-loop glucose control in adolescents with Type 1 diabetes: an outpatient, randomized, crossover trial"],"prefix":"10.48130","volume":"2026","author":[{"given":"Richell S.","family":"Booijink","sequence":"first","affiliation":[{}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Job S.","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loes","family":"Van Den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodorus J.P.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floor S.","family":"Neijens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianne C.","family":"Van Bon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27968","reference":[{"key":"key-10.48130\/pedi-0026-0009-1","doi-asserted-by":"publisher","unstructured":"

Gong B, Yang W, Xing Y, Lai Y, Shan Z. 2025. Global, regional, and national burden of type 1 diabetes in adolescents and young adults. Pediatric Research<\/ext-link><\/i> 97(2):568\u2212576<\/p>","DOI":"10.1038\/S41390-024-03107-5"},{"key":"key-10.48130\/pedi-0026-0009-2","doi-asserted-by":"publisher","unstructured":"

The Diabetes Control and Complications Trial Research Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine<\/ext-link><\/i> 329(14):977\u2212986<\/p>","DOI":"10.1056\/NEJM199309303291401"},{"key":"key-10.48130\/pedi-0026-0009-3","doi-asserted-by":"publisher","unstructured":"

Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, et al. 2012. The T1D exchange clinic registry. The Journal of Clinical Endocrinology & Metabolism<\/ext-link><\/i> 97(12):4383\u22124389<\/p>","DOI":"10.1210\/jc.2012-1561"},{"key":"key-10.48130\/pedi-0026-0009-4","doi-asserted-by":"publisher","unstructured":"

Ebekozien O, Mungmode A, Sanchez J, Rompicherla S, Demeterco-Berggren C, et al. 2023. Longitudinal trends in glycemic outcomes and technology use for over 48, 000 people with type 1 diabetes (2016\u20132022) from the T1D exchange quality improvement collaborative. Diabetes Technology & Therapeutics<\/ext-link><\/i> 25(11):765\u2212773<\/p>","DOI":"10.1089\/DIA.2023.0320"},{"key":"key-10.48130\/pedi-0026-0009-5","doi-asserted-by":"publisher","unstructured":"

De Bock M, Agwu JC, Deabreu M, Dovc K, Maahs DM, et al. 2024. International society for pediatric and adolescent diabetes clinical practice consensus guidelines 2024: glycemic targets. Hormone Research in Paediatrics<\/ext-link><\/i> 97(6):546\u2212554<\/p>","DOI":"10.1159\/000543266"},{"key":"key-10.48130\/pedi-0026-0009-6","doi-asserted-by":"publisher","unstructured":"

Elsayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, et al. 2023. Children and adolescents: standards of care in diabetes\u20142023<\/i>. Diabetes Care<\/ext-link><\/i> 46(Supplement_1):S230\u2212S253<\/p>","DOI":"10.2337\/DC23-S014"},{"key":"key-10.48130\/pedi-0026-0009-7","doi-asserted-by":"publisher","unstructured":"

Khadilkar A, Oza C. 2022. Glycaemic control in youth and young adults: challenges and solutions. Diabetes, Metabolic Syndrome and Obesity<\/ext-link><\/i> 15:121\u2212129<\/p>","DOI":"10.2147\/DMSO.S304347"},{"key":"key-10.48130\/pedi-0026-0009-8","doi-asserted-by":"publisher","unstructured":"

Kelsey MM, Zeitler PS. 2016. Insulin resistance of puberty. Current Diabetes Reports<\/ext-link><\/i> 16(7):64<\/p>","DOI":"10.1007\/S11892-016-0751-5"},{"key":"key-10.48130\/pedi-0026-0009-9","doi-asserted-by":"publisher","unstructured":"

Zhu J, Volkening LK, Laffel LM. 2020. Distinct patterns of daily glucose variability by pubertal status in youth with type 1 diabetes. Diabetes Care<\/ext-link><\/i> 43(1):22\u221228<\/p>","DOI":"10.2337\/DC19-0083\/-\/DC1"},{"key":"key-10.48130\/pedi-0026-0009-10","doi-asserted-by":"publisher","unstructured":"

Malik FS, Sauder KA, Isom S, Reboussin BA, Dabelea D, et al. 2022. Trends in glycemic control among youth and young adults with diabetes: the SEARCH for diabetes in youth study. Diabetes Care<\/ext-link><\/i> 45(2):285\u2212294<\/p>","DOI":"10.2337\/DC21-0507"},{"key":"key-10.48130\/pedi-0026-0009-11","doi-asserted-by":"publisher","unstructured":"

Fang M, Xu Y, Ballew SH, Coresh J, Echouffo-Tcheugui JB, et al. 2025. Trends and disparities in technology use and glycemic control in type 1 diabetes. JAMA Network Open<\/ext-link><\/i> 8(8):e2526353\u2212e2526353<\/p>","DOI":"10.1001\/JAMANETWORKOPEN.2025.26353"},{"key":"key-10.48130\/pedi-0026-0009-12","doi-asserted-by":"publisher","unstructured":"

Beck RW, Bergenstal RM, Laffel LM, Pickup JC. 2019. Advances in technology for management of type 1 diabetes. The Lancet<\/ext-link><\/i> 394:1265\u22121273<\/p>","DOI":"10.1016\/S0140-6736(19)31142-0"},{"key":"key-10.48130\/pedi-0026-0009-13","doi-asserted-by":"publisher","unstructured":"

Fan W, Deng C, Xu R, Liu Z, Leslie RD, et al. 2025. Efficacy and safety of automated insulin delivery systems in patients with type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetes & Metabolism Journal<\/ext-link><\/i> 49(2):235\u2212251<\/p>","DOI":"10.4093\/DMJ.2024.0130"},{"key":"key-10.48130\/pedi-0026-0009-14","doi-asserted-by":"publisher","unstructured":"

Zeng B, Gao L, Yang Q, Jia H, Sun F. 2023. Automated insulin delivery systems in children and adolescents with type 1 diabetes: a systematic review and meta-analysis of outpatient randomized controlled trials. Diabetes Care<\/ext-link><\/i> 46(12):2300\u22122307<\/p>","DOI":"10.2337\/dc23-0504"},{"key":"key-10.48130\/pedi-0026-0009-15","doi-asserted-by":"publisher","unstructured":"

Di Molfetta S, Di Gioia L, Caruso I, Cignarelli A, Green SC, et al. 2024. Efficacy and safety of different hybrid closed loop systems for automated insulin delivery in people with type 1 diabetes: a systematic review and network meta-analysis. Diabetes\/Metabolism Research and Reviews<\/ext-link><\/i> 40(6):e3842<\/p>","DOI":"10.1002\/dmrr.3842"},{"key":"key-10.48130\/pedi-0026-0009-16","doi-asserted-by":"publisher","unstructured":"

De Visser HS, Waraich S, Chhabra M, Yamamoto J, Zenlea I, et al. 2025. Automated insulin delivery systems and glucose management in children and adolescents with type 1 diabetes: a systematic review and meta-analysis. JAMA Pediatrics<\/ext-link><\/i> 179(11):1162\u22121171<\/p>","DOI":"10.1001\/JAMAPEDIATRICS.2025.2740"},{"key":"key-10.48130\/pedi-0026-0009-17","doi-asserted-by":"publisher","unstructured":"

Azar S, Maroun Abou Jaoude N, K\u0119dzia A, Niechcia\u0142 E. 2024. Barriers to type 1 diabetes adherence in adolescents. Journal of Clinical Medicine<\/ext-link><\/i> 13(19):5669<\/p>","DOI":"10.3390\/JCM13195669"},{"key":"key-10.48130\/pedi-0026-0009-18","doi-asserted-by":"publisher","unstructured":"

Blauw H, van Bon AC, Koops R, DeVries JH. 2016. Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home. Diabetes, Obesity and Metabolism<\/ext-link><\/i> 18(7):671\u2212677<\/p>","DOI":"10.1111\/DOM.12663"},{"key":"key-10.48130\/pedi-0026-0009-19","doi-asserted-by":"publisher","unstructured":"

Blauw H, Onvlee AJ, Klaassen M, van Bon AC, DeVries JH. 2021. Fully closed loop glucose control with a bihormonal artificial pancreas in adults with type 1 diabetes: an outpatient, randomized, crossover trial. Diabetes Care<\/ext-link><\/i> 44(3):836\u2212838<\/p>","DOI":"10.2337\/dc20-2106"},{"key":"key-10.48130\/pedi-0026-0009-20","doi-asserted-by":"publisher","unstructured":"

Blauw H, Wendl I, Devries JH, Heise T, Jax T, et al. 2016. Pharmacokinetics and pharmacodynamics of various glucagon dosages at different blood glucose levels. Diabetes, Obesity & Metabolism<\/ext-link><\/i> 18(1):34\u221239<\/p>","DOI":"10.1111\/dom.12571"},{"key":"key-10.48130\/pedi-0026-0009-21","doi-asserted-by":"publisher","unstructured":"

van Bon AC, Blauw H, Jansen TJP, Laverman GD, Urgert T, et al. 2024. Bihormonal fully closed-loop system for the treatment of type 1 diabetes: a real-world multicentre, prospective, single-arm trial in the Netherlands. The Lancet Digital Health<\/ext-link><\/i> 6(4):e272\u2212e280<\/p>","DOI":"10.1016\/S2589-7500(24)00002-5"},{"key":"key-10.48130\/pedi-0026-0009-22","doi-asserted-by":"publisher","unstructured":"

Gold AE, MacLeod KM, Frier BM. 1994. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care<\/ext-link><\/i> 17(7):697\u2212703<\/p>","DOI":"10.2337\/diacare.17.7.697"},{"key":"key-10.48130\/pedi-0026-0009-23","doi-asserted-by":"publisher","unstructured":"

Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, et al. 1995. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care<\/ext-link><\/i> 18(4):517\u2212522<\/p>","DOI":"10.2337\/DIACARE.18.4.517"},{"key":"key-10.48130\/pedi-0026-0009-24","doi-asserted-by":"publisher","unstructured":"

Podwojniak A, Flemming J, Tan IJ, Ghani H, Neubauer Z, et al. 2024. Cutaneous adverse effects from diabetes devices in pediatric patients with type 1 diabetes mellitus: systematic review. JMIR Dermatology<\/ext-link><\/i> 7:e59824<\/p>","DOI":"10.2196\/59824"},{"key":"key-10.48130\/pedi-0026-0009-25","doi-asserted-by":"publisher","unstructured":"

Cummings C, Benjamin NE, Prabhu HY, Cohen LB, Goddard BJ, et al. 2022. Habit and diabetes self-management in adolescents with type 1 diabetes. Health Psychology<\/ext-link><\/i> 41(1):13\u221222<\/p>","DOI":"10.1037\/HEA0001097"},{"key":"key-10.48130\/pedi-0026-0009-26","doi-asserted-by":"publisher","unstructured":"

Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, et al. 2008. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care<\/ext-link><\/i> 31(5):934\u2212939<\/p>","DOI":"10.2337\/DC07-1967"},{"key":"key-10.48130\/pedi-0026-0009-27","doi-asserted-by":"publisher","unstructured":"

Laesser CI, Piazza C, Schorno N, Nick F, Kastrati L, et al. 2025. Simplified meal announcement study (SMASH) using hybrid closed-loop insulin delivery in youth and young adults with type 1 diabetes: a randomised controlled two-centre crossover trial. Diabetologia<\/ext-link><\/i> 68(2):295\u2212307<\/p>","DOI":"10.1007\/S00125-024-06319-W"},{"key":"key-10.48130\/pedi-0026-0009-28","doi-asserted-by":"publisher","unstructured":"

Kadiyala N, Lakshman R, Allen J, Ware J, Boughton CK, et al. 2025. Fully closed-loop improves glycemic control compared with pump with CGM in adolescents with type 1 diabetes and HbA1c above target: a two-center, randomized crossover study. Diabetes Technology & Therapeutics<\/ext-link><\/i> 27(9):719\u2212727<\/p>","DOI":"10.1089\/DIA.2025.0062"},{"key":"key-10.48130\/pedi-0026-0009-29","doi-asserted-by":"publisher","unstructured":"

Nefs G, Jansen TJP, Klaassen M, Vlaskamp LB, Out M, et al. 2026. User experiences of a bihormonal fully closed-loop system among adults with type 1 diabetes in a real-world setting: a qualitative analysis. Diabetes Technology & Therapeutics<\/ext-link><\/i> 28(4):360\u2212373<\/p>","DOI":"10.1177\/15209156251383522"},{"key":"key-10.48130\/pedi-0026-0009-30","doi-asserted-by":"publisher","unstructured":"

Wilson LM, Jacobs PG, Castle JR. 2020. Role of glucagon in automated insulin delivery. Endocrinology and Metabolism Clinics of North America<\/ext-link><\/i> 49(1):179\u2212202<\/p>","DOI":"10.1016\/j.ecl.2019.10.008"},{"key":"key-10.48130\/pedi-0026-0009-31","doi-asserted-by":"publisher","unstructured":"

Urakami T, Kuwabara R, Habu M, Okuno M, Suzuki J, et al. 2014. Basal insulin requirement of youth with type 1 diabetes differs according to age. Journal of Diabetes Investigation<\/ext-link><\/i> 5(4):442\u2212444<\/p>","DOI":"10.1111\/JDI.12161"}],"container-title":["Pediatric Diabetes"],"original-title":[],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:12:53Z","timestamp":1788333173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.maxapress.com\/article\/doi\/10.48130\/pedi-0026-0009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.48130\/pedi-0026-0009","relation":{},"ISSN":["1399-5448"],"issn-type":[{"value":"1399-5448","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}